Final days to apply! 📢
SMA Europe’s 13th Call for Research Proposals closes on 30 September 2026, 16:00 UTC+1.
Submit your proposal here:
đź”— https://www.sma-europe.eu/our-call-for-research-proposals
@sma-europe.bsky.social
@sma-europe.bsky.socialFinal days to apply! 📢
SMA Europe’s 13th Call for Research Proposals closes on 30 September 2026, 16:00 UTC+1.
Submit your proposal here:
đź”— https://www.sma-europe.eu/our-call-for-research-proposals
@timgrecco.bsky.social“Now we have a model to better understand these devastating diseases, and work toward regenerative therapies for them.”
@sma-europe.bsky.socialSMA Europe’s 13th Call for Research Proposals closes on 30 September 2026!
Submit your proposal before the deadline:
đź”— https://www.sma-europe.eu/our-call-for-research-proposals
@dhsc-answers.bsky.socialA question on #SpinalMuscularAtrophy #Screening tabled by Freddie van Mierlo on 10-09-2026 has been answered by Dame Diana Johnson. https://questions-statements.parliament.uk/written-questions/detail/2026-09-10/29038
@pharmaphorum.bsky.social#ScholarRock has won its first product #approval, 14 years after it was founded, as the #FDA gives a green light to its #spinalmuscularatrophy (SMA) therapy Isembyld.
@dhsc-answers.bsky.socialA question on #SpinalMuscularAtrophy #Screening tabled by Adrian Ramsay on 25-06-2026 has been answered by Dame Diana Johnson. https://questions-statements.parliament.uk/written-questions/detail/2026-06-25/13410